Cargando…
Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646108/ http://dx.doi.org/10.1186/2051-1426-3-S2-O16 |
| _version_ | 1782400916208484352 |
|---|---|
| author | Pesonen, Sari Lundin, Johan Linder, Nina Turkki, Riku Ristimäki, Ari Joensuu, Timo Kairemo, Kalevi Partanen, Kaarina Alanko, Tuomo Jäger, Elke Karbach, Julia Wahle, Claudia Hemminki, Akseli Backman, Charlotta von Euler, Mikael Hakonen, Tiina Ranki, Tuuli Vuolanto, Antti Jäderberg, Magnus Zamarin, Dmitry |
| author_facet | Pesonen, Sari Lundin, Johan Linder, Nina Turkki, Riku Ristimäki, Ari Joensuu, Timo Kairemo, Kalevi Partanen, Kaarina Alanko, Tuomo Jäger, Elke Karbach, Julia Wahle, Claudia Hemminki, Akseli Backman, Charlotta von Euler, Mikael Hakonen, Tiina Ranki, Tuuli Vuolanto, Antti Jäderberg, Magnus Zamarin, Dmitry |
| author_sort | Pesonen, Sari |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646108 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46461082015-11-20 Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival Pesonen, Sari Lundin, Johan Linder, Nina Turkki, Riku Ristimäki, Ari Joensuu, Timo Kairemo, Kalevi Partanen, Kaarina Alanko, Tuomo Jäger, Elke Karbach, Julia Wahle, Claudia Hemminki, Akseli Backman, Charlotta von Euler, Mikael Hakonen, Tiina Ranki, Tuuli Vuolanto, Antti Jäderberg, Magnus Zamarin, Dmitry J Immunother Cancer Oral Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646108/ http://dx.doi.org/10.1186/2051-1426-3-S2-O16 Text en Copyright © 2015 Pesonen et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Pesonen, Sari Lundin, Johan Linder, Nina Turkki, Riku Ristimäki, Ari Joensuu, Timo Kairemo, Kalevi Partanen, Kaarina Alanko, Tuomo Jäger, Elke Karbach, Julia Wahle, Claudia Hemminki, Akseli Backman, Charlotta von Euler, Mikael Hakonen, Tiina Ranki, Tuuli Vuolanto, Antti Jäderberg, Magnus Zamarin, Dmitry Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title | Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title_full | Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title_fullStr | Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title_full_unstemmed | Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title_short | Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival |
| title_sort | local immunotherapy with oncos-102 shapes harmful tumor associated cd68+ macrophages to become beneficial cells that correlate with increased overall survival |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646108/ http://dx.doi.org/10.1186/2051-1426-3-S2-O16 |
| work_keys_str_mv | AT pesonensari localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT lundinjohan localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT lindernina localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT turkkiriku localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT ristimakiari localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT joensuutimo localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT kairemokalevi localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT partanenkaarina localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT alankotuomo localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT jagerelke localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT karbachjulia localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT wahleclaudia localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT hemminkiakseli localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT backmancharlotta localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT voneulermikael localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT hakonentiina localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT rankituuli localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT vuolantoantti localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT jaderbergmagnus localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival AT zamarindmitry localimmunotherapywithoncos102shapesharmfultumorassociatedcd68macrophagestobecomebeneficialcellsthatcorrelatewithincreasedoverallsurvival |